APA (7th ed.) Citation

Zafar, A., Rashid, A. A., Moeed, A., Tahir, M. J., Khan, A. J., Shrateh, O. N., & Ahmed, A. Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: A systematic review and meta-analysis. BMC.

Chicago Style (17th ed.) Citation

Zafar, Amjad, Asma Abdul Rashid, Abdul Moeed, Muhammad Junaid Tahir, Ahmad Jamal Khan, Oadi N. Shrateh, and Ali Ahmed. Safety and Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors in Patients with Pre-treated Advanced Stage Malignant Mesothelioma: A Systematic Review and Meta-analysis. BMC.

MLA (9th ed.) Citation

Zafar, Amjad, et al. Safety and Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors in Patients with Pre-treated Advanced Stage Malignant Mesothelioma: A Systematic Review and Meta-analysis. BMC.